Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: What exactly did the Js have to go to trial with?
Believe me, I hope you are correct. The disclosures made to date are intentionally (IMHO) ambiguous and therefore subject to multiple interpretations. Tailor-made for TPL and negotiation leverage. PTSC is walking a very fine and dangerous line here. There is plenty of room to provide more information to shareholders (management's fiduciary duty) without compromising TPL's flexibility. Just because other companies do the same thing doesn't make it right, or legal.
Share
New Message
Please login to post a reply